ClinicalTrials.Veeva

Menu

AQT90 FLEX NTproBNP2 Test Kit Method Comparison Study

R

Radiometer

Status

Enrolling

Conditions

Diagnostic Test

Study type

Observational

Funder types

Industry

Identifiers

NCT06693050
DC-087457

Details and patient eligibility

About

The purpose of this study is to verify performance claims for method comparison for the NTproBNP2 Test Kit on the AQT90 FLEX analyzer in whole blood (WB) and plasma (PL).

Enrollment

100 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Subjects must be able to understand given information and demonstrate willingness and ability to voluntarily give a signed, valid written informed consent to participate in the study.
  • Subjects must be 18 years of age or older.
  • Subjects with expected NT-proBNP concentrations within the measuring range of NTproBNP2 assay.

Exclusion criteria

  • Subjects known to be pregnant or breast-feeding.
  • Subjects previously enrolled in the study.
  • Subject, who has withdrawn consent.

Trial contacts and locations

3

Loading...

Central trial contact

Camilla Marvig

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems